Pheochromocytoma typical manifestations

Written by Chen Yu Fei
Neurosurgery
Updated on September 03, 2024
00:00
00:00

For pheochromocytoma, the term usually refers to tumors arising from the chromaffin tissue of the neural crest. Clinically, the main typical symptoms include severe hypertension, along with nausea, vomiting, intense headache, and dizziness. Additionally, it may also cause the patient to be in a continuous high metabolic state, characterized by persistent hyperglycemia, nausea, vomiting, and excessive sweating. If not treated promptly and effectively, it may pose serious threats to the patient's heart, brain, and kidneys. In severe cases, it could even be life-threatening. Surgery is commonly recommended for treatment.

Other Voices

doctor image
home-news-image
Written by Chen Yu Fei
Neurosurgery
47sec home-news-image

What medication is used for pheochromocytoma?

For patients with pheochromocytoma, it is advisable to choose antihypertensive drugs during medication. Clinically, there are many types of antihypertensive drugs used to treat pheochromocytoma patients, such as alpha-adrenergic receptor blockers, beta-adrenergic receptor blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors, vasodilators, catecholamine synthesis inhibitors, etc. These drugs can achieve desirable therapeutic effects. Of course, the main treatment for pheochromocytoma is through surgical methods. Only by effectively removing the tumor through surgery can a satisfactory therapeutic effect be achieved, fundamentally leading to a complete cure. (Please use medication under the guidance of a doctor.)

doctor image
home-news-image
Written by Chen Yu Fei
Neurosurgery
44sec home-news-image

How is pheochromocytoma diagnosed?

For patients with pheochromocytoma, comprehensive examinations are necessary for diagnosis. For instance, measuring catecholamines and their metabolites in blood or urine can help determine if there is a noticeable increase in catecholamine levels. Furthermore, adrenal CT scans can be used to assess the condition, where in many cases, significant occupying lesions can be detected through adrenal CT scans. In addition, other related tests also hold diagnostic value and significance, such as magnetic resonance imaging, ultrasound, and related nuclear scanning tests, which can assist in qualitative and locational diagnosis.

doctor image
home-news-image
Written by Chen Yu Fei
Neurosurgery
40sec home-news-image

Pheochromocytoma typical manifestations

For pheochromocytoma, the term usually refers to tumors arising from the chromaffin tissue of the neural crest. Clinically, the main typical symptoms include severe hypertension, along with nausea, vomiting, intense headache, and dizziness. Additionally, it may also cause the patient to be in a continuous high metabolic state, characterized by persistent hyperglycemia, nausea, vomiting, and excessive sweating. If not treated promptly and effectively, it may pose serious threats to the patient's heart, brain, and kidneys. In severe cases, it could even be life-threatening. Surgery is commonly recommended for treatment.

doctor image
home-news-image
Written by Chen Yu Fei
Neurosurgery
43sec home-news-image

Is pheochromocytoma a cancer?

Pheochromocytoma is not a cancer. It is a special type of tumor tissue that usually originates from the neuroectodermal chromaffin tissue. It can secrete catecholamines. Based on the specific origins of the tumor cells, it can be divided into types such as parasympathetic, paraganglioma, sympathetic, and ganglioneuroma. Most often, it presents with long-term hypertension, which can cause damage to the heart, brain, and kidneys due to prolonged hypertension, or severe increases in blood pressure can lead to hypertensive brain hemorrhage, thereby endangering the patient's life. Early treatment is often necessary.

doctor image
home-news-image
Written by Gan Jun
Endocrinology
49sec home-news-image

Can malignant pheochromocytoma be cured?

When pheochromocytoma becomes malignant, it can be cured through clinical approaches, although malignant pheochromocytoma mainly refers to those that have distant metastases. It primarily exhibits aggressive growth or is accompanied by metastases to other organs, and surgery cannot completely remove it, leading to a high recurrence rate post-surgery. Generally, the five-year survival rate for patients with malignant pheochromocytoma does not exceed half. If treated with chemotherapy or arterial embolization, it can control the patient's blood pressure and alleviate the tumor burden, thereby extending the survival period. In summary, the treatment of malignant pheochromocytoma is relatively challenging, has a high recurrence rate, and poses a significant threat to human life.